Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case against

Journal of Endocrinological Investigation

Volumn 35, Issue 6, 2012, Pages 616-618

  Losa, M ^a   Crippa, V G ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Acromegaly; Somatostatin

Indexed keywords

OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ANESTHESIA COMPLICATION; CARDIOMYOPATHY; GLYCEMIC CONTROL; GROWTH HORMONE SECRETING ADENOMA; HYPERTENSION; MACROGLOSSIA; NOTE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PROGNATHIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK ASSESSMENT; TRACHEOSTOMY; TRANSSPHENOIDAL SURGERY;

EID: 84863969219     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03345798     Document Type: Note

References (22)

1. Melmed S, Colao A, Barkan A, et al Acromegaly Consensus Group. Guidelines for acromegaly management: An update. J Clin Endocrinol Metab 2009, 94: 1509-17.
2. Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol 2005, 152: 379-87. (Pubitemid 40439490)
3. Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M. Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 2005, 56: 1222-33; discussion 1233.
4. Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 2006, 83: 230-9. (Pubitemid 44578877)
5. Stevenaert A, Beckers A. Presurgical octreotide treatment in acromegaly. Metabolism 1996, 45 (Suppl 1): 72-4.
6. Colao A, Ferone D, Cappabianca P, et al. Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 1997, 82: 3308-14. (Pubitemid 27419077)
7. Biermasz NR, van Dulken H, Roelfsema E. Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared with those in untreated matched controls. J Clin Endocrinol Metab 1999, 84: 3551-5. (Pubitemid 30645204)
8. Kristof RA, Stoffel-Wagner B, Klingmuller D, Schramm J. Does octreotide treatment improve the surgical results of macroadenomas in acromegaly? A randomized study. Acta Neurochir (Wien) 1999, 141: 399-405. (Pubitemid 29192189)
9. Abe T, Ludecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 2001, 145: 137-45. (Pubitemid 32707599)
10. Plockinger U, Quabbe HJ. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long term case-control study. Acta Neurochir (Wien) 2005, 147: 485-93; discussion 493.
11. Losa M, Mortini P, Urbaz L, Ribotto P, Castrignanò T, Giovanelli M. Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates. J Neurosurg 2006, 104: 899-906. (Pubitemid 43824739)
12. Petersenn S, Buchfelder M, Reincke M, et al Participants of the German Acromegaly Register. Results of surgical and somatostain analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. Eur J Endocrinol 2008, 159: 525-32.
13. Carlsen SM, Lund-Johansen M, Schreiner T, et al; Preoperative Octreotide Treatment of Acromegaly study group. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective randomized trial. J Clin Endocrinol Metab 2008, 93: 2984-90.
14. Mao ZG, Zhu YH, Tang HL, et al. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial. Eur J Endocrinol 2010, 162: 661-6.
15. Shen M, Shou X, Wang Y, et al. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study. Endocr J 2010, 57: 1035-44.
16. Bates PR, Carson MN, Trainer PJ, Wass JA; UK National Acromegaly Register Study Group (UKAR-2). Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 2008, 68: 136-42. (Pubitemid 350243493)
17. Giustina A, Chanson P, Bronstein MD, et al Acromegaly Consensus Group. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010, 95: 3141-8.
18. Beckers A. Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question. J Clin Endocrinol Metab 2008, 93: 2975-7.
19. Losa M, Mortini P, Giovanelli M. Is presurgical treatment with somatostatin analogs necessary in acromegalic patients. J Endocrinol Invest 1999, 22: 871-3. (Pubitemid 30081513)
20. Schmitt H, Buchfelder M, Radespiel-Troger M, Fahlbusch R. Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology 2000, 93: 110-4. (Pubitemid 30436684)
21. Cozzi R, Baldelli R, Colao A, Lasio G, Zini M, Attanasio R; Italian Association of Clinical Endocrinologists (AME). AME position statement on clinical management of acromegaly. J Endocrinol Invest 2009, 32 (6 Suppl): 2-25.
22. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK; AACE Acromegaly Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly - 2011 update: executive summary. Endocr Pract 2011, 17: 636-46.